Table 1.
The level of pro-inflammatory cytokines IL-1β, IL-2, TNF-α, IFN-α, IFN-γ, and TGF-β.
| Cytokine | Control Group | ACS | p-Value | Increment |
|---|---|---|---|---|
| IL-1β (pg/mL) | 21.7 (±12.25) | 45.50 (±15.39) | p = 0.0003 | ↑ 216% |
| TNF-α (pg/mL) | 356.33 (±105.53) | 752.33 (±169.20) | p < 0.0001 | ↑ 211% |
| IL-2 (pg/mL) | 95 (89–121.30) | 126 (111.5–156) | p = 0.011 | ↑ 133% |
| IFN-γ (pg/mL) | 206.50 (204.50–299.80) | 304 (245–340) | p = 0.033 | ↑ 128% |
| TGF-β (pM) | 100 (86.25–98.75) | 97 (94.25–102) | p = 0.678 | N/S |
| IFN-α (pg/mL) | 11.50 (9.25–19.75) | 16 (12.75–24.75) | p = 0.091 | N/S |
Pro-inflammatory cytokines concentration was measured in plasma from ACS patients (n = 12) and healthy subjects (n = 12). For normally distributed data, the Student’s t-test was used and the results were presented as the mean ± SD, while for the non-normally distributed results, the Mann–Whitney U test was used, and data were presented as the median with interquartile range. Statistically significant p-values (p < 0.05) are marked in bold, while N/S means no significance.